Announcement For Opnion By European Authorities On Tavneos
BRIEF-Kissei Pharmaceutical Co Ltd - Announcement For Opnion By European Authorities On Tavneos June 29 (Reuters) - Kissei Pharmaceutical Co Ltd 4547.T:
KISSEI PHARMACEUTICAL CO LTD: ANNOUNCEMENT FOR OPNION BY EUROPEAN AUTHORITIES ON TAVNEOS
KISSEI PHARMACEUTICAL CO LTD: ON JUNE 26, THE CHMP RECOMMENDED REVOKING THE MARKETING AUTHORIZATION IN THE EUROPEAN UNION FOR TAVNEOS, STATING THAT IT HAD NOT BEEN DEMONSTRATED THAT THE BENEFITS OUTWEIGH THE RISKS
KISSEI PHARMACEUTICAL CO LTD: THE CHMP'S OPINION HAS BEEN SUBMITTED TO THE EUROPEAN COMMISSION (EC), AND A FINAL DECISION BY THE EC IS EXPECTED LATER
KISSEI PHARMACEUTICAL CO LTD: KISSEI WILL CONTINUE THE DISCUSSIONS REGARDING THE APPROPRIATE MEASURES IN JAPAN WITH THE MINISTRY OF HEALTH, LABOUR AND WELFARE AND THE PHARMACEUTICALS AND MEDICAL DEVICES AGENCY
KISSEI PHARMACEUTICAL CO LTD: THE IMPACT OF THIS MATTER ON KISSEI’S BUSINESS PERFORMANCE IS CURRENTLY UNDER REVIEW
Source text: ID:nTSrb8e3df
Further company coverage: 4547.T
(Reporting by Tokyo Newsroom)
((+81345201189;))